Form 4: Amylyx Pharmaceuticals CFO Receives Stock Grant
Insider Transaction (Form 4)
James M Frates, Chief Financial Officer of Amylyx Pharmaceuticals, Inc., received 22,807 shares of common stock on August 18, 2026.
Summary
- Grant/award: acquired 22,807 Common Stock on August 18, 2026; holds 244,435 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James M Frates — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Grant/award | Common Stock | 22,807 | — | — | 244,435 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Grant/award (22,807 shares) |
Keywords
insider transaction, Form 4, AMLX, Amylyx Pharmaceuticals, Inc., neutral, James M Frates
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.